Casper, Corey http://orcid.org/0000-0002-3609-661X
Corey, Lawrence http://orcid.org/0000-0002-2179-2436
Cohen, Jeffrey I.
Damania, Blossom
Gershon, Anne A. http://orcid.org/0000-0002-4298-8155
Kaslow, David C. http://orcid.org/0000-0003-3557-383X
Krug, Laurie T. http://orcid.org/0000-0002-9648-522X
Martin, Jeffrey
Mbulaiteye, Sam M. http://orcid.org/0000-0002-8273-9831
Mocarski, Edward S.
Moore, Patrick S. http://orcid.org/0000-0002-8132-858X
Ogembo, Javier Gordon http://orcid.org/0000-0001-6949-8693
Phipps, Warren
Whitby, Denise
Wood, Charles
Article History
Received: 1 April 2022
Accepted: 2 September 2022
First Online: 20 September 2022
Competing interests
: The authors declare no competing interests. P.S.M. has a KSHV vaccine patent assigned to the University of Pittsburgh, J.G.O. has a KSHV vaccine patent assigned to the Beckman Research Institute of City of and L.T.K. has a patent for generating reversion-free attenuated and/or replication-incompetent vaccine vectors and has divested herself of potential earnings.